Poster Spotlight 8: Beyond the Scale—Obesity and GLP-1 Therapies in Breast Cancer
Session Details
The text of the abstracts will be posted on Monday, November 24.
Moderator
Lindsay Peterson, Washington University in St. Louis, St. Louis, MO
Presentation numberPD8-01
Weight Trajectories in the Breast Cancer Weight Loss (BWEL) Trial (Alliance)
Chao Cao, Dana-Farber Cancer Institute, Boston, MA
Presentation numberPD8-02
Evaluating weight loss outcomes in patients with hormone receptor-positive breast cancer on endocrine therapy receiving concurrent weight loss medications
Travis Adamson, Valley Health System, Paramus, NJ
Presentation numberPD8-03
Impact of Obesity in Premenopausal Women with Early-Stage HR+/HER2- Breast Cancer Treated With Adjuvant Endocrine Therapy
Poornima Saha, Endeavor Health, Chicago, IL
Presentation numberPD8-04
Discussant: Obesity
Saba Shaikh, UT Health San Antonio, San Antonio, TX
Presentation numberPD8-05
A Retrospective Cohort Study on Mitigating Chemotherapy Side Effects in Breast Cancer Patients: The Role of GLP-1 Agonists
Elvis Obomanu, Jefferson-Eintein Hospital, Philadelphia, PA
Presentation numberPD8-06
Real-world analysis on the impact of glucagon-like peptide-1 receptor agonists on all-cause mortality and endocrine therapy-tolerability in obese breast cancer patients
Colton Jones, University of Texas Health Science Center San Antonio, San Antonio, TX
Presentation numberPD8-07
Real-world glucagon-like peptide-1 use and association with clinical characteristics, social determinants, and circulating tumor DNA positivity in patients with breast cancer
Cleo A. Ryals, Flatiron Health, New York, NY
Presentation numberPD8-08
Glp-1 receptor agonists are associated with improved breast cancer outcomes in dcis patients on hormonal therapy: a real-world cohort study
Ali Y Khan, West Virginia University, Morgantown, WV
Presentation numberPD8-09
Revisiting the GLP‑1-pCR Link in TNBC: Contrasting Outcomes in a High‑BMI, Majority‑Hispanic Cohort
Daniela Urueta Portillo, UT Health Mays Cancer Center, San Antonio, TX
Presentation numberPD8-10
Glp-1 receptor agonist in combination with radiotherapy significantly delays tumor growth and improves overall survival in a murine model of triple negative breast cancer
Shiao L Stephen, Cedars-Sinai Medical Center, Los Angeles, CA
Presentation numberPD8-11
Discussant: GLP1
Jasmine Singh Sukumar, MD Anderson Cancer Center, Houston, TX